Dopamine releasing effect of phenylbiguanide in rat striatal slices

  • Myron Benuck
  • Maarten E. A. Reith
Article
Received:
Accepted:

Summary

The present study explored the mechanisms underlying the dopamine releasing effect of phenylbiguanide, a compound commonly used as a 5-HT3 receptor agonist. Phenylbiguanide, and also serotonin and 2-methyl-serotonin, enhanced the outflow of radioactivity from superfused rat striatal slices preloaded with [3H]dopamine. The presence of the dopamine uptake blocker nomifensin prevented the increase in outflow. The effect of phenylbiguanide was not antagonized by 5-HT3 receptor antagonists, did not require the presence of Ca2+ in the superfusion buffer, and also occurred in reserpinized preparations with depleted dopamine stores. Phenylbiguanide caused a greater shift in the distribution of superfusate radioactivity from DOPAC to dopamine than did nomifensin. All these results are in agreement with an exchange mechanism by which phenylbiguanide promotes the efflux of dopamine by operation of the uptake carrier in the reversed direction. In consonance, phenylbiguanide, and also serotonin and 2-methyl-serotonin, inhibited the binding of [3H]CFT to dopamine uptake sites, although the rank order for promoting outflow, serotonin > phenylbiguanide > 2-methyl-serotonin, differed from that for inhibiting [3H]CFT binding to dopamine uptake sites, 2-methylserotonin ∼ serotonin > phenylbiguanide. The present results raised the possibility that phenylbiguanide has an additional activity in releasing vesicular dopamine into the cytoplasmic pool.

Key words

Phenylbiguanide 5-HT3 receptor agonists 5-HT3 receptor antagonists Dopamine transporter Dopamine release Rat striatum 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Andrews DW, Patrick L, Barchas JD (1978) The effects of 5-hydroxytryptophan and 5-hydroxytryptamine on dopamine synthesis and release in rat brain striatal synaptosomes. J Neurochem 30:465–470Google Scholar
  2. Arbilla S, Langer SZ (1980) Influence of monoamine oxidase inhibition on the release of [3H]dopamine elicited by potassium and by amphetamine from the rat substantia nigra and corpus striatum. Naunyn-Schmiedeberg's Arch Pharmacol 311:45–52Google Scholar
  3. Blandina P, Goldfarb J, Craddock-Royal B, Green JP (1989) Release of endogenous dopamine by stimulation of 5-hydroxytryptamine3 receptors in rat striatum. J Pharmacol Exp Ther 251:803–809Google Scholar
  4. Bobillier PP, Salvert D, Ligier M, Seguin S (1976) Differential projections of nucleus raphe dorsalis and nucleus raphe centralis as revealed by radioautography. Brain Res 113:449–486Google Scholar
  5. Bonnet JJ, Benmansour S, Costentin J, Parker EM, Cubeddu LX (1990) Thermodynamic analyses of the binding of substrates and uptake inhibitors on the. neuronal carrier of dopamine labeled with [3H]GBR 12783 or [3H]mazindol. J Pharm Exp Ther 253:1206–1214Google Scholar
  6. Chen J, van Praag HM, Gardner EL (1991) Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens. Brain Res 543:354–357Google Scholar
  7. Costall B, Naylor RJ, Tyers MB (1990) The psychopharmacology of 5-HT3 receptors. Pharmac Ther 47:181–202Google Scholar
  8. Cubeddu LX, Hoffmann IS, Ferrari GB (1979) Metabolism and efflux of [3H]dopamine in rat neostriatum: presynaptic origin of 3,4[3H]dihydroxyphenylacetic acid. J Pharmacol Exp Ther 209:165–175Google Scholar
  9. De Belleroche JS, Bradford HF (1980) Presynaptic control of the synthesis and release of dopamine from striatal synaptosomes: a comparison between the effects of 5-hydroxytryptamine, acetylcholine, and glutamate. J Neurochem 35:1227–1234Google Scholar
  10. Debler EA, Sershen H, Hashim A, Lajtha A, Reith MEA (1991) Carrier-mediated efflux of [3H]dopamine and [3H]1-methyl-4phenylpyridine: effect of ascorbic acid. Synapse 7:99–105Google Scholar
  11. De Lean A, Munson PJ, Rodbard D (1978) Simultaneous analysis of families of sigmoidal curves: application to bioassay, and physiological dose-response curves. Am J Physiol 235:E97-E102Google Scholar
  12. Diliberto PA, Jeffs RA, Cubeddu LX (1989) Effects of low extracellular chloride on dopamine release and the dopamine transporter. J Pharmacol Exp Ther 248:644–653Google Scholar
  13. Dwoskin L, Zahniser NR (1986) Robust modulation of [3H]dopamine release from striatal slices by D-2 dopamine receptors. J Pharmacol Exp Ther 239:442–453Google Scholar
  14. Ennis C, Kemp JD, Cox B (1981) Characterization of inhibitory 5-hydroxytryptamine receptors that modulate dopamine release in the striatum. J Neurochem 36:1515–1520Google Scholar
  15. Fibiger HC, Miller JJ (1977) An anatomical and electrophysiological investigation of the serotonergic projection from the dorsal raphe nucleus to the substantia nigra in the rat. Neuroscience 2:975–978Google Scholar
  16. Fischer JF, Cho AK (1979) Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. J Pharmacol Exp Ther 208:203–209Google Scholar
  17. Herdon H, Strupish J, Nahorski SR (1985) Differences between the release of radiolabelled and endogenous dopamine from superfused rat brain slices: Effects of depolarizing stimuli, amphetamine, and synthesis inhibition. Brain Res 348:309–320Google Scholar
  18. Herve D, Pickel VM, Joh TH, Beaudet A (1987) Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons. Brain Res 435:71–83Google Scholar
  19. Kilpatrick GJ, Jones BL, Tyers MB (1987) Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding. Nature 330:746–748Google Scholar
  20. Kilpatrick GJ, Jones BJ, Tyers MB (1989) Binding of the 5-HT3 ligand, [3H]GR65630, to rat area postrema, vagus nerve and the brains of several species. Eur J Pharmacol 159:157–164Google Scholar
  21. Kilpatrick GJ, Butler A, Hagan RM, Jones BJ, Tyers MB (1990) [3H]GR67330, a very high affinity ligand for 5-HT3 receptors. Naunyn-Schmiedeberg's Arch Pharmacol 342:22–30Google Scholar
  22. Langeloh A, Trendelenburg U (1987) The mechanism of the 3H-noradrenaline releasing effect of various substrates, of uptake1: role of monoamine oxidase and of vesicularly stored 3H-noradrenaline. Naunyn-Schmiedeberg's Arch Pharmacol 336:611–620Google Scholar
  23. Madras BK, Spealman RD, Fahey MA, Neumeyer JL, Saha JK, Milius RA (1989) Cocaine receptors labeled by [3H]2β-carbomethoxy-3β-(4-fluorophenyl)tropane. Mol Pharmacol 36:518–524Google Scholar
  24. Nedergaard S, Bolan JP, Greenfield SA (1988) Facilitation of a dendritic calcium conductance by 5-hydroxytryptamine in the substantia nigra. Nature 333:174–177Google Scholar
  25. Nurse B, Russell VA, Taljaard JJF (1988) Characterization of the effects of serotonin on the release of [3H]dopamine from rat nucleus accumbens and striatal slices. Neurochem Res 13:403–407Google Scholar
  26. Parker EM, Cubeddu LX (1986a) Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores. J Pharmacol Exp Ther 237:179–192Google Scholar
  27. Parker EM, Cubeddu LX (1986b) Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. 11. Release in the presence of vesicular transmitter stores. J Pharmacol Exp Ther 237:193–203Google Scholar
  28. Parker EM, Cubeddu LX (1988) Comparative — effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding. J Pharmacol Exp Ther 245:199–210Google Scholar
  29. Paton DM (1976) Characteristics of efflux of noradrenaline from adrenergic neurons. In: Paton DM (ed) The mechanism of neuronal and extraneuronal transport of catecholamines. Raven Press, New York, pp 155–174Google Scholar
  30. Petrie EC, Lombrozo L, Csernansky JG (1990) A microassay for measuring synaptosomal 3H-metabolite release. Brain Res Bull 25:423–427Google Scholar
  31. Raiteri M, Marchi M, Maura G (1984) Release of catecholamines, serotonin and acetylcholine from isolated brain tissue. In: Lajtha A (ed) Handbook of Neurochemistry, vol 6. Plenum, New York, pp 431–462Google Scholar
  32. Ross SB (1976) Structural requirements for uptake, into catecholamine neurons. In: Paton DM (ed) The mechanism of neuronal and extraneuronal transport of catecholamines. Raven Press, New York, pp 67–93Google Scholar
  33. Ross SB, Renyi AL (1975) Tricyclic antidepressant agents. I: Comparison of the inhibition of the uptake of 3H-noradrenaline and 14C-5-hydroxytryptamine in slices and crude synaptosome preparations of the midbrain-hypothalamus region of the rat brain. Acta Pharmacol Toxicol 36:382–394Google Scholar
  34. Schmidt CJ, Black CK (1989) The putative 5-HT3 agonist phenylbiguanide induces carrier-mediated release of [3H]dopamine. Eur J Pharmacol 167:309–310Google Scholar
  35. Saskan EG, Snyder SH (1970) Kinetics of serotonin accumulation into slices from rat brain: relationship to catecholamine uptake. J Pharmacol Exp Ther 175:404–418Google Scholar
  36. Yi SJ, Gifford AN, Johnson KM (1991) Effect of cocaine and 5-HT3 receptor antagonist on 5-HT-induced [3H]dopamine release from rat striatal synaptosomes. Eur J Pharmacol 199:185–189Google Scholar
  37. Zimamyi I, Lajtha A, Reith MEA (1989) Comparison of characteristics of dopamine uptake and mazindol binding in mouse striatum. Naunyn-Schmiedeberg's Arch Pharmacol 340:626–632Google Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • Myron Benuck
    • 1
  • Maarten E. A. Reith
    • 1
  1. 1.Division of NeurochemistryN.S. Kline Institute for Psychiatric ResearchOrangeburgNYUSA

Personalised recommendations